All stock lists
Ironwood Pharmaceuticals Inc (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
Healthcare · Drug Manufacturers - Specialty & Generic
$4.78-$0.09 (-1.85%)
Insider Score
––Not scored
IRWD Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
IRWD Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
| Revenue | $133.04 M | $113.04 M | $106.51 M | $47.71 M | $122.06 M |
| Revenue Growth (YoY) | 9.00 % | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | $11.55 M | $11.31 M | $12.03 M | $19.29 M | $21.91 M |
| R&D Expense | $28.35 M | $22.42 M | $21.94 M | $21.86 M | $22.47 M |
| Operating Expenses | $39.91 M | $33.73 M | $33.97 M | $41.16 M | $44.38 M |
| Operating Income | $93.13 M | $79.31 M | $72.53 M | $6.55 M | $77.68 M |
| Pretax Income | $87.60 M | $73.73 M | $65.17 M | $455.00 K | $68.02 M |
| Tax Provision | $27.76 M | $22.44 M | $24.40 M | $2.73 M | $27.94 M |
| Net Income | $59.84 M | $51.29 M | $40.77 M | -$2.28 M | $40.08 M |
| EPS (Basic) | $0.36 | $0.31 | $0.25 | -$0.01 | $0.25 |
| EPS (Diluted) | $0.36 | $0.31 | $0.24 | -$0.01 | $0.23 |
| Shares Outstanding | 164.90 M | 164.41 M | 163.45 M | 162.44 M | 162.22 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
